Global Enoxaparin Sodium Market Growth: USD 3.03 Billion in 2024 to USD 5.11 Billion by 2032, Growing at a 7.7% CAGR
Global Enoxaparin Sodium Market is witnessing strong growth driven by rising cases of venous thromboembolism (VTE), increasing surgical procedures, and expanding applications in acute coronary syndrome (ACS) management. Enoxaparin Sodium, a widely used low molecular weight heparin, offers predictable anticoagulation, high clinical efficacy, and reduced monitoring requirements, making it a preferred choice across hospitals and outpatient care. Growing adoption in obstetrics, oncology, nephrology, and cardiology further supports market expansion. Despite challenges such as biosimilar competition and stringent regulations, opportunities in emerging markets, improved delivery systems, and strengthened thromboprophylaxis guidelines continue to shape the market’s long-term growth trajectory.